Ying Sun1, Quanyi Wang1, Guoyan Yang2, Changying Lin1, Yi Zhang1, Peng Yang1,3,4. 1. a Institute for Infectious Diseases and Endemic Diseases Control, Beijing Center for Disease Prevention and Control (CDC) , Beijing , P.R. China ; 2. b School of Basic Medical Science , Beijing University of Chinese Medicine , Beijing , P.R. China ; 3. c School of Public Health , Capital Medical University , Beijing , P.R. China ; 4. d Beijing Research Center for Preventive Medicine , Beijing , P.R. China.
Abstract
BACKGROUND: In 2009, a novel influenza A(H1N1)pdm09 virus was detected and caused influenza pandemic. It is important to identify the risk factors for severe outcomes. However, inconsistent results regarding the effect of obesity were reported in previous studies. METHODS: We conducted a systematic review to assess the association between obesity and poor prognosis for laboratory-confirmed A(H1N1)pdm09 influenza. We searched three English databases and three Chinese databases for relevant studies from April 2009 to October 2015: PubMed, the Cochrane library, Embase, CNKI, CBM, and Wanfang. Two investigators independently identified eligible articles, assessed quality using NOS, and extracted data. We performed meta-analyses and meta-regressions to estimate the association between weight and poor prognosis for influenza A(H1N1)pdm09 infection, when data were available. RESULTS: We identified 22 articles enrolling 25,189 laboratory confirmed patients. The pooled estimates indicated obesity significantly increased the risk of fatal and critical complications of influenza A(H1N1)pdm09 infection (for fatal, OR = 1.81, 95% CI: 1.23-2.65; for critical complications, OR = 1.67, 95% CI: 1.13-2.47). However, we found significant interaction between early antiviral treatment and obesity (β = -0.28). After adjustment for early antiviral treatment, relationship between obesity and poor outcomes disappeared (OR = 1.14, 95% CI: 0.94-1.39). CONCLUSIONS: The results of the meta-analyses showed obesity significantly increased the risk of death, critical complications, and severe complications for influenza A(H1N1)pdm09 infection, especially among high-quality studies and in Asia region. Importantly, the result from our meta-regression indicated that the conclusion should be interpreted with caution, because early antiviral treatment might be a key confounding factor.
BACKGROUND: In 2009, a novel influenza A(H1N1)pdm09 virus was detected and caused influenza pandemic. It is important to identify the risk factors for severe outcomes. However, inconsistent results regarding the effect of obesity were reported in previous studies. METHODS: We conducted a systematic review to assess the association between obesity and poor prognosis for laboratory-confirmed A(H1N1)pdm09 influenza. We searched three English databases and three Chinese databases for relevant studies from April 2009 to October 2015: PubMed, the Cochrane library, Embase, CNKI, CBM, and Wanfang. Two investigators independently identified eligible articles, assessed quality using NOS, and extracted data. We performed meta-analyses and meta-regressions to estimate the association between weight and poor prognosis for influenza A(H1N1)pdm09 infection, when data were available. RESULTS: We identified 22 articles enrolling 25,189 laboratory confirmed patients. The pooled estimates indicated obesity significantly increased the risk of fatal and critical complications of influenza A(H1N1)pdm09 infection (for fatal, OR = 1.81, 95% CI: 1.23-2.65; for critical complications, OR = 1.67, 95% CI: 1.13-2.47). However, we found significant interaction between early antiviral treatment and obesity (β = -0.28). After adjustment for early antiviral treatment, relationship between obesity and poor outcomes disappeared (OR = 1.14, 95% CI: 0.94-1.39). CONCLUSIONS: The results of the meta-analyses showed obesity significantly increased the risk of death, critical complications, and severe complications for influenza A(H1N1)pdm09 infection, especially among high-quality studies and in Asia region. Importantly, the result from our meta-regression indicated that the conclusion should be interpreted with caution, because early antiviral treatment might be a key confounding factor.
Authors: T D Pham; M H Y Chng; K M Roskin; K J L Jackson; K D Nguyen; J Glanville; J-Y Lee; E G Engleman; S D Boyd Journal: Mucosal Immunol Date: 2017-04-19 Impact factor: 7.313
Authors: Nadine Assmann; Katie L O'Brien; Raymond P Donnelly; Lydia Dyck; Vanessa Zaiatz-Bittencourt; Róisín M Loftus; Paul Heinrich; Peter J Oefner; Lydia Lynch; Clair M Gardiner; Katja Dettmer; David K Finlay Journal: Nat Immunol Date: 2017-09-18 Impact factor: 25.606
Authors: Almudena Laris González; Mónica Villa Guillén; Briceida López Martínez; Ana E Gamiño Arroyo; Sarbelio Moreno Espinosa; Rodolfo Norberto Jiménez Juárez; José Luis Sánchez Huerta; Daniela de la Rosa Zamboni Journal: Influenza Other Respir Viruses Date: 2018-04-19 Impact factor: 4.380